Note: This is for informational purposes only. Doctors cannot provide a diagnosis or individual treatment advice via e-mail. Please consult your physician about your specific health care concerns.
Dr. Martin J. Edelman is Professor of
Medicine at the University of Maryland School
of Medicine and Director of Solid Tumor
Oncology and Co-Leader of the Experimental
Therapeutics Program for the University of
Maryland Greenebaum Cancer Center (UMGCC). He
received his medical degree from the Albany
Medical College and completed his internship
and residency in internal medicine and a
fellowship in mematology and oncology at the
Naval Medical Center in San Diego.
After leaving military service, Dr. Edelman
joined the faculty at the University of
California at Davis and the VA Northern
California Health Care System in 1990. He
later became Chief of the Division of
Hematology and Oncology at the VA. While at
Davis he was co-director of the thoracic
oncology program and developed several trials
in lung cancer. He also initiated trials in
genito-urinary malignancies, developmental
therapeutics, and supportive care. Dr.
Edelman was a member of the lung cancer and
genito-urinary committees of the Southwest
Oncology Group (SWOG) and has chaired two
national trials in lung cancer.
Dr. Edelman joined the University of Maryland
Greenebaum Cancer Center in 1999. He is a
member of the thoracic oncology program and
currently chairs several trials in thoracic
malignancies. He is institutional Principal
Investigator for the Cancer and Leukemia
Group B at the University of Maryland. He is
also a member of the Respiratory Core
Committee of the Cancer and Leukemia Group B
and the Lung Cancer Committee of the
Radiation Therapy Oncology Group. He
currently leads two national studies
(CALGB 30801 and RTOG 0839), both based upon
pilot studies done at the UMGCC.
He is the author of over 200 articles,
abstracts, and book chapters.